Arca
Skip to content
Tools
Tools

Hepatitis C virus genotype 1 or 4

Drug research and approvals for hepatitis C virus genotype 1 or 4: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 0 studies of hepatitis C virus genotype 1 or 4 are recruiting on ClinicalTrials.gov, and Health Canada has authorized 5 drug trials for it since 2013.

  • Recruiting worldwide: 0
  • Trials authorized in Canada: 5
  • FDA orphan approvals: 0
  • EU medicines: 0

Trials authorized in Canada

Newest first; search them all in Canada trials
Oct 22, 2015An open-label, multicenter study to evaluate the pharmacokinetics, safety, and efficacy of ombitasvir (OBV), paritaprevir (PTV), ritonavir (RTV) with or…Paritaprevir (ABT-450)-ritonavir-ombitasvir (ABT-267)/ Dasabuvir (ABT-333)/…AbbViePending
Jul 10, 2015Open-label study to evaluate the safety and efficacy of the combination of ombitasvir, paritaprevir/r ± dasabuvir with ribavirin (RBV) in adult patients with…Paritaprevir (ABT-450)-ritonavir-ombitasvir (ABT-267)/ Dasabuvir (ABT-333)/…AbbVieClosed
Feb 14, 2014A phase 3, multicenter, open-label study to investigate the efficacy and safety of sofosbuvir/ledipasvir fixed-dose combination for 12 weeks in subjects with…Sofosbuvir-ledipasvir / RibavirinGilead SciencesOngoing
Oct 9, 2013A phase 2, multicenter, open-label study to investigate the safety and efficacy of sofosbuvir/ledipasvir fixed-dose combination + ribavirin administered in…Sofosbuvir-ledipasvir/ RibavirinGilead SciencesOngoing
Jun 14, 2013"a phase 3 open label study evaluating the efficacy and safety of pegylated interferon LAMBDA-1A, in combination with ribavirin and delatasvir, for treatment…BMS-914143/ Daclatasvir/ RibavirinBristol-Myers SquibbOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.